Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
Not yet recruiting · NCT07418372 · Registry updated 2026-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Clostridium infectious disease, Corynebacterium Infections, Infections, bacterial infectious disease, bordetellosis, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, pertussis, respiratory system disorder, respiratory tract infectious disorder, tetanus | Not yet recruiting | Phase 1 / Phase 2 | 2026-02-18 | NCT07418372 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jiangjin District Center for Disease Control and Prevention | Chongqing | China | 1 |